Caseload outcome credentialing: taking from the have-nots.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to James W Jones.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A prominent vascular surgeon is approached by a representative of a large medical device company with a proposal to implant a new self-sealing patch for closing open carotid endarterectomies. The patch is made of a new synthetic material that establishes immediate hemostasis and inhibits restenosis in animal studies. It has just been approved for human use by the Food and Drug Administration. The cost of the new patch is much higher than for established comparable products, even when potential long-term benefits are considered, but using it would reduce the operative time required for achieving hemostasis. The manufacturer's representative tells you that the company will pay a selected group of vascular surgeons $500 apiece each time they insert the patch on their patients and complete a one-page report. Surgeons with the highest volume of cases utilizing the patch will be offered a paid clinical consultancy with the company. You've used another company's product for several years and found it entirely satisfactory, but have followed development of the new patch with interest and considered trying it in your patients having carotid endarterectomies. What should you do? A. Join the study. You probably would have used the new patch on your patients anyway. B. If the early data warrant, implant the patch on a trial basis without enrolling in the project, and finally decide whether to continue using it based on your clinical experience and additional published reports. C. Call some of the other investigators who have already enrolled in the project and ask them about their experience. D. Decline the invitation immediately. Refuse to ever speak to the representative again. E. Estimate the ability of your patients to sustain the high cost of the new product and decide accordingly whether to use it.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Using the indirect enzyme-linked immunosorbent assay (ELISA) technique, we compared the immune response of specific antibodies (IgM and IgG) in serum samples of scrub typhus-infected and non-infected mice against Orientia sutsugamushi (a causative agent of scrub typhus). Two different age groups (4-week-old and 10-week-old) of ICR laboratory mice were infected with O. tsutsugamushi by the animal passage procedure. Serum samples were detected for scrub typhus-specific antibodies using ELISA technique. Results from determining the presence of IgM and IgG in the serum samples obtained from scrub typhus-infected mice showed that the IgG was first detected on day-13 after the initial infection in both the 4-week-old and 10-week-old mice. The IgG titer levels of both groups were not significantly different. Although the presence of IgM in the in serum samples obtained from scrub typhus-infected mice was first detected on day 13 in the 4-week-old mice and on day-12 in the 10-week-old mice, the IgM titer in the 4-week-old mice was slightly lower than in the 10-week-old mice. Clinical observations of the scrub typhus-infected mice showed that the older mice become ill on day 9 whereas the younger mice exhibited the symptoms on day 12. Considering the earlier detection and slightly higher level of specific IgM antibody, it could be interpreted that the older mice may appear to have responded against O. tsutsugamushi faster than the younger mice.
Explore the source record for details and available documents.
A knowledge, attitude, and practice (KAP) survey and an extensive entomologic survey were conducted in two sub-districts of Kamphaeng Phet province, Thailand, to test the hypothesis that correct dengue knowledge and practice reduce dengue vector populations. We found a negative association between respondents' knowledge of preventive measures and the number of unprotected containers in and around their houses. Knowledge of development sites was positively associated with unprotected containers. No relationships existed between knowledge of dengue and adult mosquito reduction practices. A higher number of unprotected containers increased the likelihood of the house being infested with one or more adult Aedes aegypti. Surprisingly, houses of respondents that used mosquito coils or had screening on doors and windows were significantly more likely to be infested (odds ratio =2.0) with adult Ae. aegypti. We conclude that there is a direct link between knowledge on dengue prevention and container protection practices, whereas measures against adult mosquitoes are used only when people experience a mosquito nuisance problem.
An elderly, widowed man with early dementia has required several surgical procedures for treatment of peripheral vascular disease over the years. Each of the operations has been performed by a single surgeon, for whom the patient and his family have developed enormous respect and admiration. The patient is quite wealthy, and at the urging of his unmarried adult daughter, his guardian, has endowed a professorship and directed that this surgeon be the first appointment to the new position. The surgeon has recently divorced, and soon after he accepts the medical school offer the daughter invites him to dinner alone at her apartment. What should he do?
Explore the source record for details and available documents.
A vascular surgeon has practiced in the same community for more than 20 years, holding privileges at the two largest local general hospitals. She is widely respected and admired by patients and fellow physicians in all specialties, and her results are consistently good. Recently, the board of directors at the hospital that has been the source of 80% of her case referrals hired a notorious slash-and-burn management firm to improve the balance sheet. The new chief executive officer (CEO) installed an information technology system that can provide management with physician-specific figures on costs and reimbursements. The management consultants identified the 10% of physicians with the worst cost/reimbursement ratios over the preceding 5 years and persuaded the board of directors to order their clinical privileges withdrawn. Our seasoned surgeon learns that she is among the targeted group. Is there an ethical issue here, and, if so, how should she respond?
Explore the source record for details and available documents.